Loading…
Lasa Supergenerics (LASA)₹4.78−4.97%Pharmaceuticals
Lasa Supergenerics is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −18.0% against a peer median of −2.8%, and latest-quarter sales growth of −100.3% against a peer median of −4.6%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medi Caps | 32 | — | −2.6 | −2.6 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | vs LASA |
| Medicamen Organics | 32 | — | −10.6 | −13.8 | 0.50 | 0.0 | 23 | −4 | −77.9 | −338.4 | vs LASA |
| Goldline Pharmaceutical | 29 | 5.0 | 30.6 | 39.4 | 0.88 | 0.0 | 31 | 4 | — | — | vs LASA |
| Medi Caps | 26 | — | −9.3 | −9.2 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | vs LASA |
| Bacil Pharma | 24 | 15.6 | — | — | 0.00 | 0.0 | 0 | 2 | — | — | vs LASA |
| Lasa Supergenerics | 24 | — | −18.0 | −19.6 | 0.20 | 0.0 | 25 | −34 | −100.3 | — | — |
| Welcure Drugs & Pharmaceuticals | 24 | — | −3.0 | −5.5 | 0.00 | 0.0 | 366 | −5 | −100.0 | −1,768.9 | vs LASA |
| Walpar Nutritions | 24 | 9.5 | 14.9 | 13.9 | 0.89 | 0.0 | 79 | 3 | 7.8 | 6.4 | vs LASA |
| Ishita Drugs & Industries | 22 | 28.3 | 8.6 | 7.0 | 0.01 | 0.0 | 15 | 1 | −32.8 | −36.7 | vs LASA |
| Venmax Drugs & Pharmaceuticals | 21 | 54.3 | 3.0 | 2.7 | 0.02 | 0.0 | 8 | 0 | 1,128.1 | −87.0 | vs LASA |
| Span Divergent | 20 | — | −30.0 | −41.5 | 0.48 | 0.0 | 17 | −3 | −4.6 | — | vs LASA |
| Peer median | 24 | 15.6 | −2.8 | −4.0 | 0.02 | 0.0 | 17 | −3 | −4.6 | −87.0 |
Listed companies closest to Lasa Supergenerics in Pharmaceuticals include Medi Caps, Medicamen Organics, Goldline Pharmaceutical, Medi Caps, Bacil Pharma, Welcure Drugs & Pharmaceuticals, Walpar Nutritions, Ishita Drugs & Industries.
Medi Caps, with a market cap of ₹31.78 Cr.
Lasa Supergenerics' return on capital employed is −18.0%, below the peer median of −2.8%.